WO1997035970A1 - Oligonucleotides utilises pour detecter vibrio parahaemolyticus et procede de detection - Google Patents
Oligonucleotides utilises pour detecter vibrio parahaemolyticus et procede de detection Download PDFInfo
- Publication number
- WO1997035970A1 WO1997035970A1 PCT/JP1997/000991 JP9700991W WO9735970A1 WO 1997035970 A1 WO1997035970 A1 WO 1997035970A1 JP 9700991 W JP9700991 W JP 9700991W WO 9735970 A1 WO9735970 A1 WO 9735970A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vibrio
- nucleic acid
- vibrio parahaemolyticus
- sequence
- seq
- Prior art date
Links
- 241000607272 Vibrio parahaemolyticus Species 0.000 title claims abstract description 55
- 238000000034 method Methods 0.000 title claims abstract description 33
- 108091034117 Oligonucleotide Proteins 0.000 title claims abstract description 22
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title claims abstract description 5
- 238000001514 detection method Methods 0.000 title description 14
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 33
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 23
- 241000607594 Vibrio alginolyticus Species 0.000 claims abstract description 6
- 108020004707 nucleic acids Proteins 0.000 claims description 11
- 102000039446 nucleic acids Human genes 0.000 claims description 11
- 230000003321 amplification Effects 0.000 claims description 5
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 5
- 108010054814 DNA Gyrase Proteins 0.000 claims description 4
- 101150076489 B gene Proteins 0.000 claims description 3
- 241000607618 Vibrio harveyi Species 0.000 claims description 3
- 230000008685 targeting Effects 0.000 claims 1
- 241000607598 Vibrio Species 0.000 abstract description 24
- 101150013736 gyrB gene Proteins 0.000 abstract description 15
- 230000001580 bacterial effect Effects 0.000 abstract description 8
- 101150012629 parE gene Proteins 0.000 abstract description 8
- 239000012634 fragment Substances 0.000 abstract description 5
- 238000007400 DNA extraction Methods 0.000 abstract description 2
- 206010047400 Vibrio infections Diseases 0.000 abstract description 2
- 101710186984 DNA gyrase subunit B Proteins 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 27
- 238000003752 polymerase chain reaction Methods 0.000 description 21
- 210000004027 cell Anatomy 0.000 description 15
- 239000000523 sample Substances 0.000 description 13
- 108090000623 proteins and genes Proteins 0.000 description 9
- 241000894006 Bacteria Species 0.000 description 8
- 230000035945 sensitivity Effects 0.000 description 8
- 239000002773 nucleotide Substances 0.000 description 7
- 125000003729 nucleotide group Chemical group 0.000 description 7
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000002609 medium Substances 0.000 description 5
- 108020003215 DNA Probes Proteins 0.000 description 4
- 239000003298 DNA probe Substances 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000607265 Vibrio vulnificus Species 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000011543 agarose gel Substances 0.000 description 3
- 125000003275 alpha amino acid group Chemical group 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 206010008631 Cholera Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 239000007984 Tris EDTA buffer Substances 0.000 description 2
- 241000602423 Vibrio cholerae O1 Species 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 239000000304 virulence factor Substances 0.000 description 2
- 230000007923 virulence factor Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000012286 Chitinases Human genes 0.000 description 1
- 108010022172 Chitinases Proteins 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 241000255925 Diptera Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000588722 Escherichia Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010016275 Fear Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001135624 Marinomonas Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108010056995 Perforin Proteins 0.000 description 1
- 241000589776 Pseudomonas putida Species 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 101710183280 Topoisomerase Proteins 0.000 description 1
- 241000544286 Vibrio anguillarum Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 108010077311 arginine oxidase Proteins 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000010876 biochemical test Methods 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000013098 chemical test method Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000003228 hemolysin Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- DHCDFWKWKRSZHF-UHFFFAOYSA-N sulfurothioic S-acid Chemical compound OS(O)(=O)=S DHCDFWKWKRSZHF-UHFFFAOYSA-N 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Definitions
- the present invention relates to an oligonucleotide primer for widening a nucleic acid target sequence characteristic of Vibrio parahaemolyticus (hereinafter sometimes abbreviated as "VP").
- the present invention provides a method for the production of Vibrio parahaemolyticus by polymerase chain reaction (PCR) using a ply specific to a DNA gyrase B subunit (hereinafter, referred to as gyr BJ) specific to a DNA jyrase subunit B gene. About the detection method.
- Vibrio parahaemolyticus is known as a food poisoning bacterium in many countries. It is also found in parts other than the intestinal tract and in postoperative scars. Vibrio parahaemolyticus is a gram-negative polymorphic rod-shaped bacterium, which is a halophilic facultative anaerobic bacterium that produces gas by fermenting carbohydrates. A dark blue mouth is formed on a thiosulfate monoquat-monobile salt-sugar (TCBS) agar medium.
- TCBS thiosulfate monoquat-monobile salt-sugar
- Vibrio parahaemolyticus is indistinguishable from Vibrio alginolyticus and Vibrio harveyi. There was only a time-consuming method to identify Vibrio alginolyticus. Vibrio consists of 37 species. All are derived from aqueous environments. According to the phylogenetic data of rRNA, known as V. anguillarum, V. ordalli, and V. darase 1a® have been transferred to newly established Listonel la ⁇ and Ph. tobacterium ⁇ . Ten species are associated with gastroenteritis, wound infection, and human sepsis, and seven are known to be pathogenic to fish.
- Vibrio parahaemolyticus usually inhabits estuarine and marine environments, and is often isolated from seawater and seafood during summer. To isolate and identify Vibrio parahaemolyticus, the sample is inoculated on a selective medium such as bromothymolbluc-teepol agar or TCBS agar, and a bluish-green colony is isolated and examined for its biochemical properties. Unfortunately, many Vibrio species respond in a similar manner, and further identification requires more detailed biochemical tests. Examining the wide range of biochemical properties of a large number of isolated strains requires a lot of effort, time and expense ( serologic identification of Vibrio parahaemolyticus shows cross-reactivity with other Vibrio strains.
- a DNA probe has been developed to identify Vibrio species from V. cholerae 01 by using a DNA probe that can specifically identify this strain by expanding the cholera beron from V. cholerae 01. Cholera that produces toxins ⁇ Interacts with other Vibrio 3 ⁇ 4 Optical label ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ (Wright, ⁇ . C. et al., Appl. Environ. Microbiol. 59: 541-546, 1993), as well as a portion of the V. vulnificus cytolysin gene (h1yA) sequence.
- a covalently labeled oligonucleotide DNA probe was generated from these probes, which did not react with non-toxic V. vulnificus and therefore did not detect all V. vulnificus .
- TDH virulence factor
- TRH virulence factor
- An object of the present invention is to provide a detection method capable of distinguishing Vibrio parahaemolyticus from other 36 Vibrio species.
- the purpose of the present invention is to provide a method for detecting a 285-bp gyrB ⁇ gene fragment unique to Vibrio parahaemolyticus from bacterial cells by a PCR method without the need for DNA extraction or other procedures using a Vibrio parahaemolyticus-specific primer .
- the present invention provides an oligonucleotide primer for the widening of 61 columns of nucleic acid targets characteristic of Vibrio parahaemolyticus. . Sequence numbers 5 and 6 are exemplified as these primers, and they are characteristic of the osteomyelitis biburi as a primer set. Used for the detection of a specific acid target sequence.
- the frimmerset is used in a method for determining the presence or absence of a nucleic acid target sequence characteristic of Vibrio parahaemolyticus. )]
- Vibrio parahaemolyticus-specific primers can be detected by the PCR method using Vibrio parahaemolyticus-specific primers.
- a “primer” is a synthetic or biologically produced oligonucleotide that contains a specific nucleotide sequence that allows hybridization to a section of the target nucleic acid sequence. It is.
- Primers can be transcribed by polymerase or similar enzymes to replicate the complete target nucleic acid sequence.
- Primers are used in nucleic acid sequence amplification methods, such as the PCR method and strand displacement amplification (SDA).
- Certain primers especially those that are useful in SDA technology, include sequences that are capable of hybridizing to the target nucleic acid, as well as restriction endonuclease recognition sequences, and polymerases or polymerases.
- Other enzymes that maintain zeo-like activity themselves contain additional sequences to direct the initiation of their type-specific oligonucleotide synthesis.
- “hybridization” refers to a specific reaction in which partially or completely complementary nucleic acid strands face each other under predetermined reaction conditions in an antiparallel (antiparallel) manner. This is the step of forming the nucleic acid of the present axe by stable hydrogen bonding.
- the wood invention relates to an oligonucleotide primer which is useful for determining the presence or absence of a nucleic acid sequence specific to Flammable vibrio. If you want to make a decision like Not only that, it can also be used as a profile for the Southern Hybridization method, which is a conventional technology.
- the primers of the present invention are unique to the gyrB subunit h sequence of Vibrio parahaemolyticus.
- the probe is specific for an internal consensus sequence within the primer spread product.
- the present inventors use a gyr B vector encoding a B subunit protein of DNA gyrase (Topoisomerase) as a highly specific probe to solve the above-mentioned problem of the prior art.
- the method was examined. There has been recently reported a method for detecting and classifying Pseudomonas putida with a universal primer that directly sequences the gyrBit gene. Using these universal primers, the yrB gene portions of various Gram-negative and positive bacteria were amplified by PCR. Using the existing primers, the present inventors expanded the 1.2 kb gyrB portion of the 37-pole vibrio. Vibrio parahaemolyticus ATCC 17802 strain of AT. The gyr B nucleotide sequence of) is shown. The present inventors further amplified only the gyrB gene of Vibrio parahaemolyticus and prepared a PCR primer capable of identification.
- the gyrB gene amplified from Vibrio parahaemolyticus ATCC 1780.2 strain and Vibrio alginoriticus ATCC 17749 strain was recombined by a 71 ⁇ method (Sambrook et al., Molecular cloning Cloning with a suitable vector according to a laboratory manual, 2nd ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. 1989).
- a preferred vector is pGEMzf (+), but any general vector can be appropriately selected and used.
- Propagation of the probe is also performed by a conventional method (Sambrook et al., 1989).
- a plasmid is used as a vector, and Escherichia coli is transformed by an effective method such as calcium chloride.
- the transformed cells are cultured under appropriate conditions.
- the target gene is collected by dissolving the bacterial cells and purified by the alkaline method. Use the purified plasmid as a sample.
- a PCR method was used. This method increases the sensitivity of the probe, and thus effectively increases the sensitivity.
- Oligonucleotide synthesized according to the nucleotide sequence of the probe Reimer not only 3 ⁇ 4 pressurized three sensitivity to amplify the DN A only if the salt 3 ⁇ 4 sequence of interest in the sample ⁇ exists, using specific oligo nucleocapsid click Reochi de based on the nucleotide sequence of the DNA probe By doing so, absolute specificity is obtained.
- the nucleotide sequences of pVP gyr B and p VA gyr were determined using a DNA sequencer in a conventional manner.
- the N-terminal and C-terminal portions of the amplified fragment were also used as UP-1S and UP-2S r primers (Yamamoto, Harayama, Appl.
- This new primer is useful in Atsushi fears (Saiki et al., Science 239: 487-491, 1988) that ffl existing PCRs.
- This primer is used to amplify the target DNA in the sample, so that the DNA can be sufficiently detected.
- the detection stage can be any method that is effective for detecting DNA. For example, agarose gel and m swimming can be used.
- the i-like DNA functions as a template.
- the width of the template DNA in the sample is the length of the primer bear.”. This is performed by treating with DNA. By this treatment, a sequence complementary to each nucleic acid sequence is extended. The extended and generated sequence further functions as a primer template.
- This process involves denaturation of DNA, annealing of the primer to a complementary sequence, and extension of the primer by a DNA polymerase (eg, Taq polymerase), which is necessary to detect the presence of the target sequence. Repeat until an amount of DNA has been generated.
- a DNA polymerase eg, Taq polymerase
- the width conditions by the PCR method are summarized in Example 3 described later.
- the amplified sequence is detected by agarose gel electrophoresis.
- the primer pair [VP1 (SEQ ID NO: 5), VP2 (SEQ ID NO: 6)] amplifies a 285 bp sequence when the yrB gene sequence is used as a target portion.
- the present invention relates to an oligonucleotide having the nucleic acid sequence obtained from SEQ ID NO: 1 and comprising at least one site that can extend the nucleic acid sequence characteristic of Vibrio parahaemolyticus.
- the present invention is characterized in that it comprises at least one site capable of amplifying a nucleic acid sequence characteristic of Vibrio parahaemolyticus having a strength obtained from SEQ ID NO: 1 and a nucleic acid sequence not obtainable from SEQ ID NO: 3 Includes oligonucleotides.
- Aeroraonas Al teromonas, Mar inomonas, Shigella,
- Vibrio parahaemolyticus A probe specific to thermostable hemolysin, one of the elements produced by Vibrio parahaemolyticus, is Reported (Nishibuchi et al., FEMS Microbiol. Lett. 55: 251-256 , 1990) ⁇ ; Specific to these toxins. Is clinically important, but cannot detect all types of Vibrio paraphylaxis. ⁇ Contamination of the product with Vibrio parahaemolyticus !; To pass, it is necessary to detect food or all types of Vibrio parahaemolyticus in its environment, from zen.
- the isolated Vibrio parahaemolyticus was examined for its phenotype, blood type and toxicity. PCR was performed on all of these 118 strains of Vibrio parahaemolyticus using the primers VP1 and VP2. A 28.5 bp sequence was amplified in Akiraka.
- Table 3 The results are shown in Table 3.
- the strains in Table 3 were isolated and identified from food, soil, water, or feces, and some were obtained from Dr. Shinoda of Okayama University and Dr. Yamamoto of Kyushu University. As shown in Table 3, in the 20 strains of Vibrio alginolyticus similarly isolated from various species, no variation in the sequence of 285 bp was observed.
- the present invention has a nucleic acid sequence obtained from SEQ ID NO: 1 and comprises at least one site capable of amplifying a nucleic acid sequence characteristic of Vibrio parahaemolyticus, but it is a nucleic acid derived from Vibrio alginoliticus and Vibrio harveyi This is an oligonucleotide characterized by the fact that the sequence cannot be very long.
- the present invention comprises a nucleic acid sequence obtained from SEQ ID NO: 1 but not obtained from SEQ ID NO: 3, and comprises at least one site capable of extending a nucleic acid sequence characteristic of Vibrio parahaemolyticus. Oligonucleotides characterized by the fact that nucleic acid sequences derived from lyticus and Vibrio harvey cannot be extended. Table 3
- a diluent of genomic DNA of B. parahaemolyticus ATCC 1780.2 ⁇ was prepared, and 1 ng of genomic DNA was used as a template for PCR.
- VP1 and VP2 were also detected from the diluent containing only DNA.
- 7-migrated DNA was applied to a southern block.
- the detection limit was about 1 cfu / reaction tube. Detection limit field by the way PCR method was 1 cfu / 1 0 1 or 1 0 3 cfu Z m 1. Plated and selective medium detection has the sensitivity to detect viable cells, but requires labor and time.
- the Atsey system by the PCR method is useful because it has an excellent balance of speed, sensitivity, and specificity required for the bacterial detection method compared to the conventional detection method.
- Example 1 The present invention will be described with reference to Examples.
- the embodiment is an embodiment of the present invention, and does not limit the present invention.
- Example 1
- Vibrio parahaemolyticus Positive for oxidase, lenticarboxylase, orchidinase carboxylase, seratinase, ribase, chitinase; indole production; solid salt concentration 0.5-8 %, Growing at 42 ° C; sensitivity to 0/129 (150 g); producing acid from glucose, mannitol, mannose; arginine dehydrogenase, arginase Negative; does not grow at a salt concentration of 0%; does not produce acid from sucrose, lactose, and saline.
- Example 2 Example 2
- the Vibrio parahaemolyticus strain was cultured in TSB medium (manufactured by Eiken) at 37 ° C with shaking for about 24 hours. Cells are collected by centrifugation (manufactured by Tomi Issei) (15, 000 rPm, 15 minutes, 4 ° C), and 10 ml of sterile TE buffer (10 mM ris, 1 mM EDTA, pH 8.0) The cells were lysed with lysozyme (final concentration: 1 mg Zm1; manufactured by Wako), and shaken gently at 37 ° C.
- the Vibrio parahaemolyticus-specific primer can be used to detect a Vibrio parahaemolyticus-specific 285 bp gyrB gene fragment from cells without PCR or other procedures.
- Sequence type nucleic acid
- AACAAAACAC CAATCATCGA GAAAATCTTC CACTTCGACT TAGAACGTGA AGACGGCATT 480
- ACGCCACTAG CCGTTGTGGG TGATACGGAT AAAACCGGTA CACAAATTCG TTTCTGGCCA 240 AGTGCCGAGA CGTTCTCTAA CACTGAGTTC CACTATGACA TTCTGGCGAA ACGCCTGCGT 300
- Sequence type nucleic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97907459A EP0965636A4 (en) | 1996-03-26 | 1997-03-25 | OLIGONUCLEOTIDES USED FOR DETECTING VIBRIO PARAHAEMOLYTICUS AND METHOD FOR DETECTING IT |
| US09/155,200 US6048697A (en) | 1996-03-26 | 1997-03-25 | Oligonucleotides used for detecting vibrio parahaemolyticus and method of detection therewith |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8095971A JPH09252783A (ja) | 1996-03-26 | 1996-03-26 | 腸炎ビブリオ検出のためのヌクレオチドおよびそれを用いた検出法 |
| JP8/95971 | 1996-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1997035970A1 true WO1997035970A1 (fr) | 1997-10-02 |
Family
ID=14152078
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP1997/000991 WO1997035970A1 (fr) | 1996-03-26 | 1997-03-25 | Oligonucleotides utilises pour detecter vibrio parahaemolyticus et procede de detection |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6048697A (ja) |
| EP (1) | EP0965636A4 (ja) |
| JP (1) | JPH09252783A (ja) |
| CA (1) | CA2249183A1 (ja) |
| WO (1) | WO1997035970A1 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0935003A3 (en) * | 1997-12-12 | 1999-10-27 | Marine Biotechnology Institute Co., Ltd. | Method for identification and detection of microorganisms using gyrase gene as an indicator |
| DE19916227A1 (de) * | 1999-04-10 | 2000-11-02 | Merlin Mikrobiolog Diag Gmbh | Verfahren zur genotypischen Klassifizierung |
| WO2004055188A1 (ja) * | 2002-12-13 | 2004-07-01 | Nichirei Foods Inc. | ビブリオコレラ又はビブリオミミカスの検出用プライマー及びプローブ並びにそれらを用いる検出方法 |
| CN107099585A (zh) * | 2017-04-21 | 2017-08-29 | 丹东出入境检验检疫局综合技术服务中心 | 海鱼弧菌检测用引物对、试剂盒及检测方法 |
| CN116555460A (zh) * | 2023-07-06 | 2023-08-08 | 暨南大学 | 副溶血弧菌的特异性分子靶标及其检测方法 |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4226234B2 (ja) * | 2001-08-03 | 2009-02-18 | 株式会社ニチレイフーズ | RNAポリメレースσ70因子をコードする遺伝子(rpoD)配列を用いた腸炎ビブリオ検出、同定、計数方法 |
| JP4021285B2 (ja) * | 2002-08-30 | 2007-12-12 | 株式会社ニチレイフーズ | ビブリオブルニフィカスの検出用プライマー及びプローブ並びにそれらを用いる検出方法 |
| FI113549B (fi) * | 2002-11-19 | 2004-05-14 | Mobidiag Oy | Diagnostinen menetelmä hengitystieinfektioita aiheuttavien bakteerien osoittamiseksi ja tunnistamiseksi ja menetelmässä käyttökelpoinen alukeseos |
| CN102108402B (zh) * | 2010-12-14 | 2013-04-24 | 陈吉刚 | 一种检测哈维氏弧菌的试剂盒及检测方法 |
| CN103243168A (zh) * | 2013-05-16 | 2013-08-14 | 汇智泰康生物技术(北京)有限公司 | 一种用于检测食品中的副溶血弧菌的试剂盒及其使用方法 |
| DE102015012691A1 (de) | 2015-09-28 | 2017-03-30 | Biotecon Diagnostics Gmbh | Verfahren zum quantitativen Nachweis von Vibrio parahaemolyticus, Vibrio vulnificus und Vibrio cholerae |
| CN106755550B (zh) * | 2017-03-16 | 2020-12-08 | 辽宁大学 | 一种水产养殖动物体内溶藻弧菌的pcr检测方法 |
| CN107012227A (zh) * | 2017-04-21 | 2017-08-04 | 丹东出入境检验检疫局综合技术服务中心 | 用于致病性弧菌检测的通用引物对及其应用 |
| CN111471782A (zh) * | 2020-05-09 | 2020-07-31 | 南开大学 | 副溶血弧菌o抗原血清型特异检测引物及多重pcr检测方法 |
| CN112280878B (zh) * | 2020-11-17 | 2023-01-31 | 南京农业大学 | 一种检测副溶血性弧菌的特异性靶点、引物、检测方法及应用 |
| CN112646907B (zh) * | 2020-12-30 | 2022-05-20 | 广东省微生物研究所(广东省微生物分析检测中心) | 含有特异性分子靶标的副溶血性弧菌标准菌株及其检测和应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04262799A (ja) * | 1991-02-18 | 1992-09-18 | Toyobo Co Ltd | 核酸配列の増幅方法およびそのための試薬キット |
| JPH05123197A (ja) * | 1991-10-30 | 1993-05-21 | Shimadzu Corp | 核酸の検出方法 |
| JPH07114719A (ja) * | 1993-10-18 | 1995-05-02 | Tanashin Denki Co | テープレコーダの回転ヘッド装置 |
| JPH07213299A (ja) * | 1994-02-02 | 1995-08-15 | Kaiyo Bio Technol Kenkyusho:Kk | Dnaジャイレース遺伝子による細菌の同定・検出法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362623A (en) * | 1991-06-14 | 1994-11-08 | The John Hopkins University | Sequence specific DNA binding by p53 |
| US5468852A (en) * | 1992-02-18 | 1995-11-21 | Shimadzu Corporation | Oligonucleotides for detecting bacteria |
-
1996
- 1996-03-26 JP JP8095971A patent/JPH09252783A/ja active Pending
-
1997
- 1997-03-25 EP EP97907459A patent/EP0965636A4/en not_active Withdrawn
- 1997-03-25 WO PCT/JP1997/000991 patent/WO1997035970A1/ja not_active Application Discontinuation
- 1997-03-25 US US09/155,200 patent/US6048697A/en not_active Expired - Fee Related
- 1997-03-25 CA CA002249183A patent/CA2249183A1/en not_active Abandoned
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04262799A (ja) * | 1991-02-18 | 1992-09-18 | Toyobo Co Ltd | 核酸配列の増幅方法およびそのための試薬キット |
| JPH05123197A (ja) * | 1991-10-30 | 1993-05-21 | Shimadzu Corp | 核酸の検出方法 |
| JPH07114719A (ja) * | 1993-10-18 | 1995-05-02 | Tanashin Denki Co | テープレコーダの回転ヘッド装置 |
| JPH07213299A (ja) * | 1994-02-02 | 1995-08-15 | Kaiyo Bio Technol Kenkyusho:Kk | Dnaジャイレース遺伝子による細菌の同定・検出法 |
Non-Patent Citations (3)
| Title |
|---|
| APPLIED AND ENVIRONMENTAL MICROBIOLOGY, Vol. 61(3), (1995), S. YAMAMOTO et al., "PCR Amplification and Direct Sequencing of gyrB Genes with Universal Primers and Their Application to the Detection and Taxonomic Analysis of Pseudomonas Putida Strains", p. 1104-1109. * |
| MICROBIAL PATHOGENESIS, Vol. 18, (1995), J. OKUDA et al., "Distribution of the Cytolethal Distending Toxin A Gene(cdtA) Among Species of Shigella and Vibrio and Cloning and Sequencing of the cdt Gene from Shigella Dysenteriae", p. 167-172. * |
| See also references of EP0965636A4 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0935003A3 (en) * | 1997-12-12 | 1999-10-27 | Marine Biotechnology Institute Co., Ltd. | Method for identification and detection of microorganisms using gyrase gene as an indicator |
| DE19916227A1 (de) * | 1999-04-10 | 2000-11-02 | Merlin Mikrobiolog Diag Gmbh | Verfahren zur genotypischen Klassifizierung |
| WO2004055188A1 (ja) * | 2002-12-13 | 2004-07-01 | Nichirei Foods Inc. | ビブリオコレラ又はビブリオミミカスの検出用プライマー及びプローブ並びにそれらを用いる検出方法 |
| CN107099585A (zh) * | 2017-04-21 | 2017-08-29 | 丹东出入境检验检疫局综合技术服务中心 | 海鱼弧菌检测用引物对、试剂盒及检测方法 |
| CN116555460A (zh) * | 2023-07-06 | 2023-08-08 | 暨南大学 | 副溶血弧菌的特异性分子靶标及其检测方法 |
| CN116555460B (zh) * | 2023-07-06 | 2023-09-22 | 暨南大学 | 副溶血弧菌的特异性分子靶标及其检测方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| US6048697A (en) | 2000-04-11 |
| JPH09252783A (ja) | 1997-09-30 |
| EP0965636A1 (en) | 1999-12-22 |
| CA2249183A1 (en) | 1997-10-02 |
| EP0965636A4 (en) | 2002-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jackson et al. | Characterization of the variable-number tandem repeats in vrrA from different Bacillus anthracis isolates | |
| WO1997035970A1 (fr) | Oligonucleotides utilises pour detecter vibrio parahaemolyticus et procede de detection | |
| Watterworth et al. | Multiplex PCR-DNA probe assay for the detection of pathogenic Escherichia coli | |
| US20090117557A1 (en) | Rapid Detection of Microorganisms | |
| JP2007117022A (ja) | リステリア・モノサイトゲネス検出のためのプライマーセットおよび方法 | |
| AU2008292946B2 (en) | Detection of bacteria belonging to the genus Campylobacter by targeting cytolethal distending toxin | |
| JP5204466B2 (ja) | マイコプラズマ・ニューモニエ(Mycoplasmapneumoniae)の検出方法 | |
| FR2694768A1 (fr) | Séquences d'oligonucléotides pour la détection spécifique de mollicutes par amplication de gènes conservés. | |
| JP4021285B2 (ja) | ビブリオブルニフィカスの検出用プライマー及びプローブ並びにそれらを用いる検出方法 | |
| JP3434818B2 (ja) | 赤痢菌同定用核酸プローブ | |
| Ibrahim et al. | Differentiation between pathogenic and non-pathogenic Yersinia enterocolitica strains by colony hybridization with a PCR-mediated digoxigenin-dUTP-labelled probe | |
| JP2007061061A (ja) | リステリア・モノサイトジェネス(Listeriamonocytogenes)の検出法 | |
| Vázquez-Marrufo et al. | Multi-typing of enterobacteria harboring LT and ST enterotoxin genes isolated from Mexican children | |
| JP2010115122A (ja) | アスペルギルスフミガタス(Aspergillusfumigatus)類縁菌の検出方法 | |
| CA2548689A1 (en) | Nucleic acids for detection of listeria | |
| JP2008005779A (ja) | ラクトバチルス・ブレビス検出のためのプライマーおよびそれを用いた検出法 | |
| CA2471230A1 (en) | New primers for the detection and identification of bacterial indicator groups and virulence factors | |
| EP0643776A1 (fr) | SEQUENCES NUCLEOTIDIQUES ISSUES DE GENES CODANT DES PECTATE-LYASES, ET LEURS UTILISATIONS NOTAMMENT POUR LA DETECTION DE BACTERIES DU GENRE -i(ERWINIA). | |
| JP2005160333A (ja) | オリゴヌクレオチド及びこれをプライマーとして用いたラクトバチルス属細菌の検出方法 | |
| Kim | Studies on PCR-based rapid detection systems for Salmonella spp. | |
| JP2935791B2 (ja) | ラクトバチルス属細菌の検出プライマー | |
| Izumi et al. | A Novel PCR detection method for major fish pathogenic bacteria of Vibrio anguillarum | |
| JP2007075017A (ja) | Campylobacterjejuniの検出法 | |
| Thomas | Integrons and integron-related antibiotic resistance in acinetobacter | |
| Genov et al. | Molecular and phenotypic characterization of Agrobacterium species from vineyards allows identification of typical A. vitis and atypical biovar 1 strains |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): CA JP US |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| CFP | Corrected version of a pamphlet front page | ||
| CR1 | Correction of entry in section i | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| ENP | Entry into the national phase |
Ref document number: 2249183 Country of ref document: CA Ref country code: CA Ref document number: 2249183 Kind code of ref document: A Format of ref document f/p: F |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1997907459 Country of ref document: EP |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 09155200 Country of ref document: US |
|
| WWP | Wipo information: published in national office |
Ref document number: 1997907459 Country of ref document: EP |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1997907459 Country of ref document: EP |